140 related articles for article (PubMed ID: 3490910)
1. Incidence and growth of methylcholanthrene-induced tumors in mice with altered immunological status.
Trutin-Ostović C; Golubić M; Matović M; Marusić M
Cancer Immunol Immunother; 1986; 23(2):130-6. PubMed ID: 3490910
[TBL] [Abstract][Full Text] [Related]
2. Suppression of basal and Corynebacterium parvum-augmented NK activity during chemically induced tumor development.
Ghoneum M; Gill G; Wojdani A; Payne C; Alfred LJ
Int J Immunopharmacol; 1987; 9(1):71-8. PubMed ID: 3583504
[TBL] [Abstract][Full Text] [Related]
3. Neonatal thymectomy and tumor induction with methylcholanthrene in mice.
Balner H; Dersjant H
J Natl Cancer Inst; 1966 Mar; 36(3):513-21. PubMed ID: 18630325
[TBL] [Abstract][Full Text] [Related]
4. The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice.
Scott MT; Warner SL
Cancer Res; 1976 Apr; 36(4):1335-8. PubMed ID: 1083289
[TBL] [Abstract][Full Text] [Related]
5. Accelerated growth of syngeneic tumors in mice treated with methylcholanthrene.
Lill PH; Jessup JM; Kripke ML
Int J Cancer; 1978 Apr; 21(4):511-5. PubMed ID: 669850
[TBL] [Abstract][Full Text] [Related]
6. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
[TBL] [Abstract][Full Text] [Related]
7. Macrophage mediated tumor cell cytotoxicity.
Kaplan AM; Morahan PS
Ann N Y Acad Sci; 1976; 276():134-45. PubMed ID: 1071961
[TBL] [Abstract][Full Text] [Related]
8. Regression and prevention of autochthonous tumors induced by 3-methylcholanthrene after injection of a T-cell receptor alpha /beta positive and CD4/CD8 double negative T-cells.
Wakasugi H; Miyazaki K; Maruoka H; Kato K; Miyata M; Sugimura T; Terada M
Immunol Lett; 1999 Sep; 69(3):329-37. PubMed ID: 10528797
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of Corynebacterium Parvum anti-tumour activity. II. Protective effect in T-cell-deprived mice.
Mazurek C; Chalvet H; Stiffel C; Biozzi G
Int J Cancer; 1977 Oct; 20(4):532-4. PubMed ID: 334678
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of antitumor action of Corynebacterium parvum: replicating short-lived T cells as the mediators of potentiated tumor-specific immunity.
Tuttle RL; North RJ
J Reticuloendothel Soc; 1976 Sep; 20(3):209-16. PubMed ID: 1086362
[No Abstract] [Full Text] [Related]
11. Relationship of tumor immunogenicity to concentration of the oncogen.
Prehn RT
J Natl Cancer Inst; 1975 Jul; 55(1):189-90. PubMed ID: 1159812
[TBL] [Abstract][Full Text] [Related]
12. Tumour metastasis in mice with reduced immune reactivity. IV. Restoration of relative resistance to metastasis formation in thymectomized sub-lethally irradiated mice by spleen cells.
Suurküla M; Boeryd B
Pathol Eur; 1975; 10(4):299-305. PubMed ID: 1208121
[TBL] [Abstract][Full Text] [Related]
13. Immune prophylaxis of experimental cancer by corynebacterium parvum.
Wrba H
Exp Pathol (Jena); 1978; 16(1-6):154-6. PubMed ID: 720440
[TBL] [Abstract][Full Text] [Related]
14. Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice.
Woodruff MF; Warner NL
J Natl Cancer Inst; 1977 Jan; 58(1):111-6. PubMed ID: 299893
[TBL] [Abstract][Full Text] [Related]
15. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
Gabizon A; Leibovich SJ; Goldman R
J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
[TBL] [Abstract][Full Text] [Related]
16. Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.
Scott MT
J Natl Cancer Inst; 1974 Sep; 53(3):861-5. PubMed ID: 4213016
[No Abstract] [Full Text] [Related]
17. An analysis of the factors allowing promotion (rather than inhibition) of tumour growth by Corynebacterium parvum.
Bomford R
Int J Cancer; 1977 May; 19(5):673-9. PubMed ID: 863546
[TBL] [Abstract][Full Text] [Related]
18. Dietary restriction reduces the incidence of 3-methylcholanthrene-induced tumors in mice: close correlation with its potentiating effect on host T cell functions.
Konno A; Hishinuma K; Hashimoto Y; Kimura S; Nishimura T
Cancer Immunol Immunother; 1991; 33(5):293-8. PubMed ID: 1868487
[TBL] [Abstract][Full Text] [Related]
19. Decreased tumor surveillance in perforin-deficient mice.
van den Broek ME; Kägi D; Ossendorp F; Toes R; Vamvakas S; Lutz WK; Melief CJ; Zinkernagel RM; Hengartner H
J Exp Med; 1996 Nov; 184(5):1781-90. PubMed ID: 8920866
[TBL] [Abstract][Full Text] [Related]
20. Immunological mechanisms in metastatic spread and the antimetastatic effects of C. parvum.
Jones PD; Castro JE
Br J Cancer; 1977 May; 35(5):519-27. PubMed ID: 193547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
